Position in SEER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$710,601
-$155,062 QoQ
Shares Held
422,977
-10.6% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. SEER ranks #332 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in SEER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $710,601 | 422,977 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $865,663 | 473,040 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,026,704 | 473,136 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,090,815 | 509,727 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $739,310 | 437,462 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $997,702 | 431,906 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $879,267 | 446,329 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $707,829 | 421,327 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,060,664 | 1,084,560 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,059,954 | 1,061,832 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,243,488 | 1,015,153 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,196,983 | 982,900 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,328,748 | 862,370 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,877,939 | 841,024 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,154,894 | 795,206 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,143,147 | 798,117 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,940,994 | 717,913 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $15,935,157 | 698,604 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $23,265,657 | 673,781 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,810,510 | 268,777 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,677,518 | 253,449 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,191,649 | 39,039 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||